{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mometasone root_notes_note in Note (approximate match)
2-Furamide is a toxic furan derivative. Intraperitoneal administration to mice at causes significant liver damage observed as centrilobular necrosis at doses 1.4-2.6 mmol/kg in mice.
Status:
US Previously Marketed
Source:
VEXOL by HARROW EYE
(1994)
Source URL:
First approved in 1994
Source:
VEXOL by HARROW EYE
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Rimexolone is a glucocorticoid receptor agonist. Rimexolone ophthalmic (for the eyes) is used to treat eye inflammation caused by infections, injury, surgery, or other conditions. It is FDA approved for the treatment of post-operative inflammation and anterior uveitis. Common adverse reactions include hypotension, erythema, pruritus, taste sense altered, headache, blurred vision, discharge from eye, pain in eye, pharyngitis, and rhinitis.